BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 26923371)

  • 1. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework.
    Varol E; Sotiras A; Davatzikos C;
    Neuroimage; 2017 Jan; 145(Pt B):346-364. PubMed ID: 26923371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disentangling Disease Heterogeneity with Max-Margin Multiple Hyperplane Classifier.
    Varol E; Sotiras A; Davatzikos C
    Med Image Comput Comput Assist Interv; 2015 Oct; 9349():702-709. PubMed ID: 28717788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining multivariate normative rules for healthy aging using neuroimaging and machine learning: an application to Alzheimer's disease.
    Andrade de Oliveira A; Carthery-Goulart MT; Oliveira Júnior PP; Carrettiero DC; Sato JR
    J Alzheimers Dis; 2015; 43(1):201-12. PubMed ID: 25079801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated atrophy assessment for Alzheimer's disease diagnosis from brain MRI images.
    Shaikh TA; Ali R
    Magn Reson Imaging; 2019 Oct; 62():167-173. PubMed ID: 31279772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
    Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
    Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boosting diagnosis accuracy of Alzheimer's disease using high dimensional recognition of longitudinal brain atrophy patterns.
    Farzan A; Mashohor S; Ramli AR; Mahmud R
    Behav Brain Res; 2015 Sep; 290():124-30. PubMed ID: 25889456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHIMERA: Clustering of Heterogeneous Disease Effects via Distribution Matching of Imaging Patterns.
    Dong A; Honnorat N; Gaonkar B; Davatzikos C
    IEEE Trans Med Imaging; 2016 Feb; 35(2):612-21. PubMed ID: 26452275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.
    Nho K; Saykin AJ; ; Nelson PT
    J Alzheimers Dis; 2016; 52(1):373-83. PubMed ID: 27003218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferability of Alzheimer's disease progression subtypes to an independent population cohort.
    Chen H; Young A; Oxtoby NP; Barkhof F; Alexander DC; Altmann A;
    Neuroimage; 2023 May; 271():120005. PubMed ID: 36907283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network.
    Zheng C; Zhao W; Yang Z; Tang D; Feng M; Guo S;
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110873. PubMed ID: 37827426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying the joint signature of brain atrophy and gene variant scores in Alzheimer's Disease.
    Cruciani F; Aparo A; Brusini L; Combi C; Storti SF; Giugno R; Menegaz G; Boscolo Galazzo I;
    J Biomed Inform; 2024 Jan; 149():104569. PubMed ID: 38104851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression.
    Wen J; Fu CHY; Tosun D; Veturi Y; Yang Z; Abdulkadir A; Mamourian E; Srinivasan D; Skampardoni I; Singh A; Nawani H; Bao J; Erus G; Shou H; Habes M; Doshi J; Varol E; Mackin RS; Sotiras A; Fan Y; Saykin AJ; Sheline YI; Shen L; Ritchie MD; Wolk DA; Albert M; Resnick SM; Davatzikos C;
    JAMA Psychiatry; 2022 May; 79(5):464-474. PubMed ID: 35262657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Alzheimer's disease based on morphology and atrophy using machine learning combined with automated segmentation.
    Ikemitsu N; Kanazawa Y; Haga A; Hayashi H; Matsumoto Y; Harada M
    Acta Radiol; 2024 Apr; 65(4):359-366. PubMed ID: 38196180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feature-ranking-based Alzheimer's disease classification from structural MRI.
    Beheshti I; Demirel H;
    Magn Reson Imaging; 2016 Apr; 34(3):252-63. PubMed ID: 26657976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of structural brain MRI and multi-parameter classification for Alzheimer's disease.
    Zhang Y; Liu S
    Biomed Tech (Berl); 2018 Jul; 63(4):427-437. PubMed ID: 28622141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative margin-sensitive autoencoder for collective multi-view disease analysis.
    Zhang Z; Zhu Q; Xie GS; Chen Y; Li Z; Wang S
    Neural Netw; 2020 Mar; 123():94-107. PubMed ID: 31837517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method and software for automatically classifying Alzheimer's disease patients by magnetic resonance imaging analysis.
    Previtali F; Bertolazzi P; Felici G; Weitschek E
    Comput Methods Programs Biomed; 2017 May; 143():89-95. PubMed ID: 28391822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Prediction of Alzheimer's Disease Using Null Longitudinal Model-Based Classifiers.
    Gavidia-Bovadilla G; Kanaan-Izquierdo S; Mataró-Serrat M; Perera-Lluna A;
    PLoS One; 2017; 12(1):e0168011. PubMed ID: 28045907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.